Exact Sciences has a multipronged approach to cancer testing. Current products are Cologuard, its flagship stool-based screening test for colorectal cancer, or CRC, and Oncotype DX, its tissue-based ...

At this time, I would like to welcome everyone to the Exact Sciences third-quarter 2024 earnings conference call. [Operator ...

At this time, I would like to welcome everyone to the Exact Sciences Third Quarter 2024 Earnings ... increasing Cologuard customer satisfaction and brand awareness to all-time highs, receiving ...

Sustainability-assured statements ensure risks not captured by financial statements are properly disclosed and evaluated ...

Leica Biosystems, a global leader in anatomic pathology, today announced non-enforcement of their Digital Pathology DICOM (Digital Imaging and Communications in Medicine) patent portfolio, to ...

Many famous entrepreneurs built their success with the help of corporate or family capital. Only a handful of people start ...

Cannabis is about so much more than getting high, and THC gummies are an ideal way to get the benefits without smoking or ...

Market Leadership and Brand Recognition: Exact Sciences Corp has established itself as a market leader in the cancer screening industry, particularly with its flagship product, Cologuard.

Market Leadership and Brand Recognition: Exact Sciences Corp has established itself as a market leader in the cancer screening industry, particularly with its flagship product, Cologuard. The ...